...
xers-img

Xeris Pharmaceuticals Inc, Common Stock

XERS

NSQ

$3.25

-$0.16

(-4.69%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$508.37M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.86M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.28
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.69 L
$3.87 H
$3.25

About Xeris Pharmaceuticals Inc, Common Stock

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase I clinical trial for the treatment of hypothyroidism; and non-aqueous XeriSol and XeriJect technologies for various therapies. The company was incorporated in 2005 and is headquartered in Chicago, Illinois. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameXERSSectorS&P500
1-Week Return-7.41%-2.06%-0.55%
1-Month Return12.07%-1.92%2.72%
3-Month Return12.07%-10.4%7.66%
6-Month Return52.58%-4.6%10.15%
1-Year Return64.14%4.06%27.53%
3-Year Return31.58%1.94%32.31%
5-Year Return-58.01%36.48%89.2%
10-Year Return-83.93%97.46%194.59%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue2.72M20.16M110.25M110.25M163.91M[{"date":"2019-12-31","value":1.66,"profit":true},{"date":"2020-12-31","value":12.3,"profit":true},{"date":"2021-12-31","value":67.26,"profit":true},{"date":"2022-12-31","value":67.26,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue1.60M9.33M22.63M22.63M28.64M[{"date":"2019-12-31","value":5.6,"profit":true},{"date":"2020-12-31","value":32.56,"profit":true},{"date":"2021-12-31","value":79.02,"profit":true},{"date":"2022-12-31","value":79.02,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit1.12M10.83M87.61M87.61M135.27M[{"date":"2019-12-31","value":0.83,"profit":true},{"date":"2020-12-31","value":8,"profit":true},{"date":"2021-12-31","value":64.77,"profit":true},{"date":"2022-12-31","value":64.77,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin41.11%53.72%79.47%79.47%82.52%[{"date":"2019-12-31","value":49.81,"profit":true},{"date":"2020-12-31","value":65.09,"profit":true},{"date":"2021-12-31","value":96.3,"profit":true},{"date":"2022-12-31","value":96.3,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses123.50M94.37M169.55M169.55M168.44M[{"date":"2019-12-31","value":72.84,"profit":true},{"date":"2020-12-31","value":55.66,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":99.34,"profit":true}]
Operating Income(122.38M)(83.55M)(81.94M)(81.94M)(44.01M)[{"date":"2019-12-31","value":-12238000000,"profit":false},{"date":"2020-12-31","value":-8354600000,"profit":false},{"date":"2021-12-31","value":-8194000000,"profit":false},{"date":"2022-12-31","value":-8194000000,"profit":false},{"date":"2023-12-31","value":-4401000000,"profit":false}]
Total Non-Operating Income/Expense(8.01M)(15.40M)(14.44M)(26.89M)(41.35M)[{"date":"2019-12-31","value":-800800000,"profit":false},{"date":"2020-12-31","value":-1539900000,"profit":false},{"date":"2021-12-31","value":-1443600000,"profit":false},{"date":"2022-12-31","value":-2689100000,"profit":false},{"date":"2023-12-31","value":-4135200000,"profit":false}]
Pre-Tax Income(126.04M)(91.25M)(96.08M)(96.08M)(63.50M)[{"date":"2019-12-31","value":-12603800000,"profit":false},{"date":"2020-12-31","value":-9125000000,"profit":false},{"date":"2021-12-31","value":-9608400000,"profit":false},{"date":"2022-12-31","value":-9608400000,"profit":false},{"date":"2023-12-31","value":-6350400000,"profit":false}]
Income Taxes(458.00K)(110.00K)(1.42M)(1.42M)(1.25M)[{"date":"2019-12-31","value":-45800000,"profit":false},{"date":"2020-12-31","value":-11000000,"profit":false},{"date":"2021-12-31","value":-142400000,"profit":false},{"date":"2022-12-31","value":-142400000,"profit":false},{"date":"2023-12-31","value":-124900000,"profit":false}]
Income After Taxes(125.58M)(91.14M)(94.66M)(94.66M)(62.26M)[{"date":"2019-12-31","value":-12558000000,"profit":false},{"date":"2020-12-31","value":-9114000000,"profit":false},{"date":"2021-12-31","value":-9466000000,"profit":false},{"date":"2022-12-31","value":-9466000000,"profit":false},{"date":"2023-12-31","value":-6225500000,"profit":false}]
Income From Continuous Operations(125.58M)(91.14M)(122.72M)(94.66M)(62.26M)[{"date":"2019-12-31","value":-12558000000,"profit":false},{"date":"2020-12-31","value":-9114000000,"profit":false},{"date":"2021-12-31","value":-12272500000,"profit":false},{"date":"2022-12-31","value":-9466000000,"profit":false},{"date":"2023-12-31","value":-6225500000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(125.58M)(91.14M)(94.66M)(94.66M)(62.26M)[{"date":"2019-12-31","value":-12558000000,"profit":false},{"date":"2020-12-31","value":-9114000000,"profit":false},{"date":"2021-12-31","value":-9466000000,"profit":false},{"date":"2022-12-31","value":-9466000000,"profit":false},{"date":"2023-12-31","value":-6225500000,"profit":false}]
EPS (Diluted)(4.80)(2.28)(1.52)(0.70)(0.45)[{"date":"2019-12-31","value":-480,"profit":false},{"date":"2020-12-31","value":-228,"profit":false},{"date":"2021-12-31","value":-152,"profit":false},{"date":"2022-12-31","value":-70,"profit":false},{"date":"2023-12-31","value":-45,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

XERS
Cash Ratio 0.76
Current Ratio 1.79
Quick Ratio 1.29

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

XERS
ROA (LTM) -8.70%
ROE (LTM) -617.16%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

XERS
Debt Ratio Lower is generally better. Negative is bad. 1.09
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.09

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

XERS
Trailing PE NM
Forward PE NM
P/S (TTM) 2.71
P/B 3.34
Price/FCF NM
EV/R 3.76
EV/Ebitda NM

FAQs

What is Xeris Pharmaceuticals Inc share price today?

Xeris Pharmaceuticals Inc (XERS) share price today is $3.25

Can Indians buy Xeris Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Xeris Pharmaceuticals Inc (XERS) on Vested. To buy Xeris Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in XERS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Xeris Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Xeris Pharmaceuticals Inc (XERS) via the Vested app. You can start investing in Xeris Pharmaceuticals Inc (XERS) with a minimum investment of $1.

How to invest in Xeris Pharmaceuticals Inc shares from India?

You can invest in shares of Xeris Pharmaceuticals Inc (XERS) via Vested in three simple steps:

  • Click on Sign Up or Invest in XERS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Xeris Pharmaceuticals Inc shares
What is Xeris Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Xeris Pharmaceuticals Inc (XERS) is $3.87. The 52-week low price of Xeris Pharmaceuticals Inc (XERS) is $1.69.

What is Xeris Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Xeris Pharmaceuticals Inc (XERS) is

What is Xeris Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Xeris Pharmaceuticals Inc (XERS) is 3.34

What is Xeris Pharmaceuticals Inc dividend yield?

The dividend yield of Xeris Pharmaceuticals Inc (XERS) is 0.00%

What is the Market Cap of Xeris Pharmaceuticals Inc?

The market capitalization of Xeris Pharmaceuticals Inc (XERS) is $508.37M

What is Xeris Pharmaceuticals Inc’s stock symbol?

The stock symbol (or ticker) of Xeris Pharmaceuticals Inc is XERS

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top